-
COST OF CARE AND BUDGET IMPACT OF FIRST-LINE (1L) TREATMENTS IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA (LA/MUC) FROM THE MEXICAN PUBLIC PAYER PERSPECTIVE
Mar 18, 2026, 21:38 PM -
NEUROLOGIST PREFERENCES FOR NEW MS TREATMENTS: IMPLICATIONS FOR MARKET ACCESS PRIORITIZATION IN THE UNITED STATES AND EUROPE
Mar 18, 2026, 21:38 PM -
COMPARING HEALTH OUTCOMES BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) STATUS AND RISK LEVEL: FINDINGS FROM THE US NATIONAL HEALTH AND WELLNESS SURVEY
Mar 18, 2026, 21:38 PM -
WHAT ARE THE VARIABLES ASSOCIATED WITH MULTIMORBIDITY AMONG UNITED STATES ADULTS WITH A DIAGNOSIS OF ARTHRITIS: FINDINGS FROM A CROSS-SECTIONAL DATABASE STUDY
Mar 18, 2026, 21:38 PM -
NATURAL HISTORY, MANAGEMENT, AND BURDEN OF DISEASE IN ADULTS WITH NF1 AND SYMPTOMATIC INOPERABLE PLEXIFORM NEUROFIBROMA IN FRANCE
Mar 18, 2026, 21:38 PM -
FORMULARY EXCLUSIONS AND NON-ADHERENCE TO DISEASE-MODIFYING THERAPIES FOR MULTIPLE SCLEROSIS IN MEDICARE PART D
Mar 18, 2026, 21:38 PM -
MIND THE GAP:EVALUATION OF ARTIFICIAL INTELLIGENCE (AI) ASSISTED EVIDENCE GAP ANALYSIS APPROACHES FOR PCSK-9 INHIBITORS
Mar 18, 2026, 21:38 PM -
RETHINKING HEALTH ECONOMIC MODELS FOR OUTCOME-ALIGNED PAYMENTS: A FRAMEWORK FOR THE NEW 2026 CMS ACCESS MODEL
Mar 18, 2026, 21:38 PM -
IMPACT OF MEDICATION CLUSTERS ON POST-DISCHARGE ADVERSE DRUG EVENTS AND HEALTHCARE UTILIZATION AMONG OLDER ADULTS
Mar 18, 2026, 21:38 PM -
OPEN ORGANIZATIONAL INNOVATION IN PUBLIC HEALTH: EVIDENCE FROM BRAZILIAN HOSPITALS AND A FRAMEWORK FOR SCALABLE, VALUE-GENERATING IMPLEMENTATION
Mar 18, 2026, 21:38 PM -
HEALTHCARE RESOURCE UTILIZATION AND COSTS OF RECURRENT STROKES IN MEDICARE FEE-FOR-SERVICE BENEFICIARIES IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
SPILLOVER EFFECTS OF US MFN POLICY ON EUROPEAN DRUG ACCESS
Mar 18, 2026, 21:38 PM -
PREDICTING PROSTATE CANCER INCIDENCE USING A LARGE, NATIONAL U.S. ELECTRONIC HEALTH RECORDS (EHR) DATABASE
Mar 18, 2026, 21:38 PM -
FROM RETRIEVAL TO VERDICT: A HYBRID LLM PIPELINE FOR EVALUATING MEDICAL AND ECONOMIC CLAIMS
Mar 18, 2026, 21:38 PM -
BUDGET IMPACT OF INTRODUCING TAPINAROF, A NEW ARYL HYDROCARBON RECEPTOR AGONIST, FOR THE TREATMENT OF ATOPIC DERMATITIS IN ADULT AND PEDIATRIC PATIENTS, FROM A U.S. MEDICAID PLAN PERSPECTIVE
Mar 18, 2026, 21:38 PM -
OPERATING ROOM EFFICIENCY AND COST IMPLICATIONS OF THULIUM FIBER LASER VERSUS HOLMIUM:YAG LASER FOR PROSTATE ENUCLEATION: A TARGETED REVIEW, ANALYSIS, AND MODEL
Mar 18, 2026, 21:38 PM -
EPIDEMIOLOGY AND TREATMENT PATTERNS OF THRYOID EYE DISEASE IN SPAIN: POPULATION-BASED REAL-WORLD EVIDENCE
Mar 18, 2026, 21:38 PM -
METHODOLOGICAL CHARACTERISTICS OF PHARMACOGENOMICS-INTEGRATED AI CLINICAL DECISION SUPPORT SYSTEMS (AI-CDSS): A SYSTEMATIC REVIEW
Mar 18, 2026, 21:38 PM -
HOW ADHERENCE DYNAMICS CHANGE POLICY CONCLUSIONS: MODELING COLORECTAL CANCER SCREENING WITH THE LONGITUDINAL ADHERENCE TRAJECTORY (LAT) FRAMEWORK
Mar 18, 2026, 21:38 PM -
REAL WORLD HEALTHCARE RESOURCE UTILIZATION AND COSTS ASSOCIATED WITH PANCREATIC CANCERIN THE BRAZILIAN PRIVATE MARKET
Mar 18, 2026, 21:38 PM
